Disclaimer: The information provided herein is my opinion only. Under any circumstances do any statement here represent a recommendation to buy or sell, nor do i make any claims or promises for profits. You are responsible for your own action.consult with your financial adviser before taking any action
Monday, December 30, 2019
Wednesday, December 11, 2019
A small cap pharma company with a market cap of 3389 cr It is a high cash reserved company.it is in a 3 year breakout
buy@402-410 levels for a tgt of 520.
mkt cap-3389, pe 13.45
sales improved during 2016-2019 is 1344 cr to 1643
net profit improved from 163 cr to 193 cr during 2016-2019
eps improved from 19.16 to 24.11 during 2016-2019.
Subscribe to:
Posts (Atom)